secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sanara MedTech Inc. (SMTI)
CIK:        0000714256
Form:       8-K
Filed at:   2024-04-05T23:59:59+00:00
Accession:  0001493152-24-013261
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sanara MedTech appoints Jake Waldrop COO and Tyler Palmer Chief Corporate Development Officer
--------------------------------------------------------------------------------

- Jake Waldrop appointed COO effective April 15, 2024; base salary $315,000, eligible for annual restricted stock and cash bonus up to 75% of salary.
- One-time restricted stock award of $100,000 granted within 30 days, vesting over two years.
- Tyler Palmer appointed Chief Corporate Development and Strategy Officer effective April 1, 2024.
- Waldrop previously VP Finance at Enovis (Foot & Ankle) and CFO at Trilliant Surgical; Palmer was SVP at AQuity Solutions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/714256/000149315224013261/0001493152-24-013261-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/714256/000149315224013261/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-013261

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer